IT1190163B - Derivati fosforilalcanolammidici della l-carnitina e composizioni farmaceutiche che li contengono - Google Patents

Derivati fosforilalcanolammidici della l-carnitina e composizioni farmaceutiche che li contengono

Info

Publication number
IT1190163B
IT1190163B IT47524/86A IT4752486A IT1190163B IT 1190163 B IT1190163 B IT 1190163B IT 47524/86 A IT47524/86 A IT 47524/86A IT 4752486 A IT4752486 A IT 4752486A IT 1190163 B IT1190163 B IT 1190163B
Authority
IT
Italy
Prior art keywords
carnitine
derivatives
pharmaceutical compositions
compositions containing
phosphorylalcanolamide
Prior art date
Application number
IT47524/86A
Other languages
English (en)
Other versions
IT8647524A0 (it
Inventor
Alberto Reiner
Original Assignee
Sigma Tau Ind Farmaceuti
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sigma Tau Ind Farmaceuti filed Critical Sigma Tau Ind Farmaceuti
Priority to IT47524/86A priority Critical patent/IT1190163B/it
Publication of IT8647524A0 publication Critical patent/IT8647524A0/it
Priority to US07/000,397 priority patent/US4784992A/en
Priority to AT87830008T priority patent/ATE43601T1/de
Priority to ES87830008T priority patent/ES2009856B3/es
Priority to EP87830008A priority patent/EP0232227B1/en
Priority to DE8787830008T priority patent/DE3760202D1/de
Priority to JP62005860A priority patent/JPS62190190A/ja
Application granted granted Critical
Publication of IT1190163B publication Critical patent/IT1190163B/it
Priority to GR89400128T priority patent/GR3000113T3/el

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/06Phosphorus compounds without P—C bonds
    • C07F9/08Esters of oxyacids of phosphorus
    • C07F9/09Esters of phosphoric acids
    • C07F9/091Esters of phosphoric acids with hydroxyalkyl compounds with further substituents on alkyl
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/06Antihyperlipidemics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biochemistry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Obesity (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IT47524/86A 1986-01-13 1986-01-13 Derivati fosforilalcanolammidici della l-carnitina e composizioni farmaceutiche che li contengono IT1190163B (it)

Priority Applications (8)

Application Number Priority Date Filing Date Title
IT47524/86A IT1190163B (it) 1986-01-13 1986-01-13 Derivati fosforilalcanolammidici della l-carnitina e composizioni farmaceutiche che li contengono
US07/000,397 US4784992A (en) 1986-01-13 1987-01-05 Phosphorylalkanolamide derivatives of L-carnitine and pharmaceutical compositions containing same
AT87830008T ATE43601T1 (de) 1986-01-13 1987-01-12 Phosphorylalkanolamid-derivate von l-carnitin und sie enthaltende arzneimittel.
ES87830008T ES2009856B3 (es) 1986-01-13 1987-01-12 Un procedimiento para producir fosforilalcanolamidas de l-carnitina.
EP87830008A EP0232227B1 (en) 1986-01-13 1987-01-12 Phosphorylalkanolamide derivatives of l-carnitine and pharmaceutical compositions containing same
DE8787830008T DE3760202D1 (en) 1986-01-13 1987-01-12 Phosphorylalkanolamide derivatives of l-carnitine and pharmaceutical compositions containing same
JP62005860A JPS62190190A (ja) 1986-01-13 1987-01-13 L−カルニチンのホスホリルアルカノ−ルアミド誘導体類およびその医薬組成物
GR89400128T GR3000113T3 (en) 1986-01-13 1989-07-24 Phosphorylalkanolamide derivatives of l-carnitine and pharmaceutical compositions containing same

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT47524/86A IT1190163B (it) 1986-01-13 1986-01-13 Derivati fosforilalcanolammidici della l-carnitina e composizioni farmaceutiche che li contengono

Publications (2)

Publication Number Publication Date
IT8647524A0 IT8647524A0 (it) 1986-01-13
IT1190163B true IT1190163B (it) 1988-02-16

Family

ID=11260878

Family Applications (1)

Application Number Title Priority Date Filing Date
IT47524/86A IT1190163B (it) 1986-01-13 1986-01-13 Derivati fosforilalcanolammidici della l-carnitina e composizioni farmaceutiche che li contengono

Country Status (8)

Country Link
US (1) US4784992A (it)
EP (1) EP0232227B1 (it)
JP (1) JPS62190190A (it)
AT (1) ATE43601T1 (it)
DE (1) DE3760202D1 (it)
ES (1) ES2009856B3 (it)
GR (1) GR3000113T3 (it)
IT (1) IT1190163B (it)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040053208A1 (en) * 1995-08-29 2004-03-18 V. I. TECHNOLOGIES, Inc. Methods to selectively inactivate parasites in biological compositions
US6352695B1 (en) * 1997-10-03 2002-03-05 V.I. Technologies, Inc. Methods and compositions for the selective modification of nucleic acids
US6093564A (en) * 1997-10-03 2000-07-25 V.I. Technologies, Inc. Methods and compositions for the selective modification of nucleic acids
IT1299266B1 (it) * 1998-05-15 2000-02-29 Sigma Tau Ind Farmaceuti Inibitori reversibili della carnitina palmitoil trasferasi
US6617100B2 (en) 1998-09-25 2003-09-09 V.I. Technologies, Inc. Solid phase quenching systems
US6403359B1 (en) 1998-09-25 2002-06-11 V. I. TECHNOLOGIES, Inc. Solid phase quenching systems
US20040019107A1 (en) 2002-07-29 2004-01-29 Floyd Taub Homeopathic drug composition and methods of use thereof
US20050232911A1 (en) * 2004-04-19 2005-10-20 Schreiber Brian D Prevention and treatment of metabolic abnormalities associated with excess intramyocellular lipid
WO2012011572A1 (ja) * 2010-07-23 2012-01-26 国立大学法人大阪大学 拡張不全型心不全治療薬

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4218404A (en) * 1976-05-06 1980-08-19 Chinoin Gyogyszer Es Vegyeszeti Termekek Gyara Rt. ω-Aminocarboxylic acid amides
HU178199B (en) * 1976-05-06 1982-03-28 Chinoin Gyogyszer Es Vegyeszet New process for producing amides of omega-amino-carboxylic acids
GB2058566A (en) * 1979-09-21 1981-04-15 Sigma Tau Ind Farmaceuti Pharmaceutical composition comprising L-carnitine
IT1209564B (it) * 1984-06-29 1989-08-30 Magis Farmaceutici Derivati della l-carnitina o di l-acil carnitina.

Also Published As

Publication number Publication date
JPS62190190A (ja) 1987-08-20
DE3760202D1 (en) 1989-07-06
EP0232227B1 (en) 1989-05-31
ATE43601T1 (de) 1989-06-15
GR3000113T3 (en) 1990-11-29
US4784992A (en) 1988-11-15
EP0232227A1 (en) 1987-08-12
ES2009856B3 (es) 1989-10-16
IT8647524A0 (it) 1986-01-13

Similar Documents

Publication Publication Date Title
US4599232A (en) Pharmaceutical composition with metabolic and energetic activity for the use in cardiac and vascular therapy
US4401827A (en) Novel acyl-derivatives of carnitine and process for their preparation
CA2292497A1 (en) Dietary compositions for enhancing metabolism and alleviating oxidative stress
KR840003414A (ko) 3-히드록시부탄산 또는 이 산으로부터 유도된 염을 함유하는 약학적 조성물과, 의약품으로 사용할 수 있는 3-히드록시부탄산으로부터 유도된 화합물
PT84217B (pt) Processo para a preparacao de derivados de quinona e de composicoes farmaceuticas que os contem
IT1190163B (it) Derivati fosforilalcanolammidici della l-carnitina e composizioni farmaceutiche che li contengono
KR940018372A (ko) 피페라진 유도체
WO1999027924A3 (fr) Agnim comme agents anti-inflammatoires dans les tissus superficiels des mammiferes
HK1005724A1 (en) Esters of acyl carnitines with long-chain aliphatic alcohols and pharmaceutical compositions containing same having antibacterial activity
DE3888415D1 (de) Salpetersäureester-Derivate.
IT1255485B (it) Processo per preparare gli acidi biliari coniugati con la glicina e relative composizioni terapeutiche per il trattamento dell'insufficienza epatica
KR950000141A (ko) 피부병 치료용 약제조성물 제조를 위한 방향족산을 함유한 l- 카르니틴 o-에스테르의 용도
PT100756A (pt) Novos derivados de gangliosidos, processo para a sua preparacao e composicoes farmaceuticas que os contem
IE43278L (en) Diphenyl sulfides.
PT82815B (pt) Processo de preparacao de derivados da imidazolidina, dos seus sais farmaceuticamente aceitaveis e das composicoes farmaceuticas que os contem
HUT34947A (en) Process for the production of benzoic acid-derivatives of antimicrobial activity
US4721728A (en) Pantothenyl derivatives
Kariya et al. Inhibition of fatty acid synthesis by RMI 14,514 (5-tetradecyloxy-2-furoic acid)
HUT42048A (en) Process for preparing benzoquinone derivatives and pharmaceutical compositions containing such compounds as active ingredients
IE880648L (en) Optically active oxo-isoindolinyl derivatives.
KR910014352A (ko) 피리딘-2,4- 및-2,5-디카복실산의 디(니트록시알킬)아미드, 이의 제조방법 및 이의 용도
ES8207128A1 (es) Procedimiento para preparar carnitinamidas
GB1313838A (en) 3,4,5-trialkoxybenzoic acid derivatives and their uses
GB1496298A (en) Esters of theophyllinylacetic acid
EP0331948A3 (en) Pharmaceutical composition for the transdermal administration of heparin

Legal Events

Date Code Title Description
TA Fee payment date (situation as of event date), data collected since 19931001

Effective date: 19941205